9
DATE: Impact of CPD/Appraisal/Revalidation on healthcare Dr Andrew Long Vice President, Education, RCPCH Consultant Paediatrician, Great Ormond Street Hospital

Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

DATE:

Impact of

CPD/Appraisal/Revalidation

on healthcare

Dr Andrew Long

Vice President, Education, RCPCH

Consultant Paediatrician, Great Ormond Street Hospital

Page 2: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

Cost benefit

The Department of Health has published a long awaited

impact assessment for revalidation, revealing that the

scheme will cost doctors over £450 in ‘opportunity costs’ per

revalidation cycle and will only prevent 0.75% of cases of

death, severe harm and moderate harm per year.

The impact assessment reveals the scheme will cost a total

of £97m a year, the majority of which accounts for the added

pressures on doctors’ time.

The impact assessment said that there will be two main

costs for revalidation: those associated with undertaking

appraisals and making revalidation decisions.

Evidence that revalidation is delivering value include:

• a continued increase in appraisal rates (which increased from 63% to 91%

between March 2011 and March 2016)

• an increased focus on the quality of appraisers and the appraisal process

• indicative signs that concerns about a doctor’s practice are being identified at an

earlier stage

• strong support for the system among responsible officers and appraisers

• strong support from doctors, appraisers and responsible officers for medical

appraisal, a key element of revalidation.

However, the report also highlights a few areas where further work is needed:

• While doctors continue to value appraisals and continuing professional

development, some feel that revalidation is not yet relevant to their needs..

• Patients and the public need clearer and more powerful roles in revalidation in the

future.

Page 3: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

The outcomes/effectiveness of revalidation in the United Kingdom:evaluating the regulatory impact of medical revalidation

Julian Archer, Niall Cameron, Katie Laugharne, Martin Marshall, Sam Regan de Bere, Kieran Walshe, Richard Wright

Page 4: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

Purpose of the evaluation

• 30 research questions, addressing 6 core regulatory aims for medical revalidation:

– Is the GMC’s objective of bringing all doctors into a governed systemthat evaluates their fitness to practise on a regular basis being consistently achieved?

– How is the requirement for all doctors to collect and reflect upon supporting information (SI) about their whole practice through appraisal being experienced by revalidation stakeholders?

– Is engagement in revalidation promoting medical professionalism by increasing doctors’ awareness and adoption of the principles and values set out in Good Medical Practice?

– Are revalidation mechanisms facilitating the identification and remedy of potential concerns before they become safety issues or FTP referrals?

– How do ROs fulfil their statutory function of advising the GMC about doctors’ fitness to practise and what support do they have in this role?

– Are patients being effectively and meaningfully engaged in revalidation processes?

Page 6: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

Patient involvementInstruments

Patient feedback questionnaires

Patient survey

Patient information from GMC and

patient groups

Patients, Public

Lay

representatives

Rules

Revalidation

processes/regulations

Fitness to Practice

Organisational Protocols

Organisational structures

Rules

Revalidation

processes/regulations

Fitness to Practice

Organisational Protocols

Organisational structures

Community

Medical Community

Patients/carers

Patient groups

Medical Institutions

DoH

NHS

Healthwatch

CCG’s

Non-medical communities

Division of Labour

Patients

Lay representatives

Doctors

Revalidation Representation

Outcome

“Up to date and fit to

practice”

Increased patient

safety and public

confidence

Current system inadequate

- further work in progress

Page 7: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

Benefits to profession

Page 8: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

Summary

• Revalidation has been implemented in the UK with numerical success

• CPD is an essential component of revalidation

– demonstrate knowledge and skills necessary

– show relationship to Good Medical Practice

• Revalidation portfolio should demonstrate professional attitude to working life

• Best outcome for patients is likely to relate to how seriously clinicians engage with the process

• Highlights the need for reflective practice

Page 9: Impact of CPD/Appraisal/RevalidationThe outcomes/effectiveness of revalidation in the United Kingdom: evaluating the regulatory impact of medical revalidation Julian Archer, Niall

Questions….?